Treatment of pituitary tumors: somatostatin. (Q36324189)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Treatment of pituitary tumors: somatostatin.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Treatment of pituitary tumors: somatostatin (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

author

Adrian F. Daly

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

author name string

Maria A Tichomirowa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

Albert Beckers

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

publication date

1 October 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

published in

Endocrine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

page(s)

93-100

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

cites work

Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptors in brain and pituitary

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncological applications of somatostatin analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lanreotide Autogel for acromegaly: a new addition to the treatment armamentarium

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic and immunologic activities and applications of somatostatin analogs

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of somatostatin receptors in normal and tumor tissue

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of patients with acromegaly and congestive heart failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dependency and analgesia related to treatment with subcutaneous octreotide in patients with growth hormone-secreting tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of somatostatin and its physiologic function

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. A follow-up of 52 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide exerts different effects in vivo and in vitro in Cushing's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The analgesic effect and development of dependency to somatostatin analogue (octreotide) in headache associated with acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

111In-octreotide scintigraphy in oncology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide dependency and headache: a case report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acromegaly: a unique human headache model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphological effects of octreotide on growth hormone-producing pituitary adenomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinically nonfunctioning pituitary adenomas.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological Improvement of Acromegalic Cardiomyopathy by Intermittent Subcutaneous Infusion of Octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presurgical Octreotide: treatment in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel modalities of somatostatin actions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogs in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New perspectives in the treatment of Cushing's syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of pituitary adenomas: a systematic review

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and functionality of the somatostatin receptor subtypes in acromegaly.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sandostatin LAR in acromegalic patients: a dose-range study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyrotropin-secreting pituitary tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesic effect of the somatostatin analogue octreotide in two acromegalic patients: a double-blind study with long-term follow-up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor imaging in somatotroph and non‐functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical results of long-term slow-release lanreotide treatment of acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for acromegaly management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pituitary tumors: pathophysiology, clinical manifestations and management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular signaling of somatostatin receptors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor subtypes: specific expression and signaling properties

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicentre study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide as primary therapy for acromegaly.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presurgical octreotide treatment in acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary medical therapy for acromegaly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The apoptotic effect of somatostatin analogue SMS 201-995 on human lymphocytes.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin Regulation of Glycoprotein Hormone and Free Subunit Secretion in Clinically Nonfunctioning and Somatotroph Adenomasin Vitro*

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pituitary carcinoma: a clinicopathological review.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical management of thyrotropin-secreting pituitary adenomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversible shrinkage of a growth hormone-secreting pituitary adenoma by a long-acting somatostatin analogue, octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular pharmacology of somatostatin receptor subtypes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin-14 and its analog octreotide exert a cytostatic effect on GH3 rat pituitary tumor cell proliferation via a transient G0/G1 cell cycle block.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Editorial: Somatostatin: newcomer from the hypothalamus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/16311415

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1385/ENDO:28:1:093

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

Dimensions Publication ID

1043806855

0 references

PubMed publication ID

16311415

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16311415

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16311415%20AND%20SRC:MED&resulttype=core&format=json

retrieved

9 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36324189&oldid=2217921248"